Home
Market Capitalization of Beta Drugs Ltd

Beta Drugs Ltd
NSE: BETA
Market Cap
Key Highlights
- The Market Cap of Beta Drugs Ltd is ₹ 1640 crore as of 13 Mar 25 .
- The Latest Trading Price of Beta Drugs Ltd is ₹ 1706 as of 13 Mar 15:30 .

Beta Drugs Ltd
NSE: BETA
Share Price
Market Price of Beta Drugs Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
13 Mar 2025 | 1706.4 |
12 Mar 2025 | 1662.7 |
11 Mar 2025 | 1690 |
10 Mar 2025 | 1696.15 |
07 Mar 2025 | 1716.1 |
06 Mar 2025 | 1817.35 |
05 Mar 2025 | 1778 |
04 Mar 2025 | 1604.25 |
03 Mar 2025 | 1595 |
28 Feb 2025 | 1649.4 |
SWOT Analysis Of Beta Drugs Ltd
BlinkX Score for Beta Drugs Ltd
Asset Value vs Market Value of Beta Drugs Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Beta Drugs Ltd
Historical P/E Ratio of Beta Drugs Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Beta Drugs Ltd
Historical Revenue of Beta Drugs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Beta Drugs Ltd
Historical EBITDA of Beta Drugs Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Beta Drugs Ltd
Historical Net Profit of Beta Drugs Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Beta Drugs Ltd
Dividend Payout Over Time
About Beta Drugs Ltd
- Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
- Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
- Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
- The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
- The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.
Beta Drugs Ltd News Hub
Beta Drugs schedules AGM
Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be held on 30 Se
Read more
02 Sept 24
Beta Drugs to conduct EGM
Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12
Read more
21 Oct 24
Beta Drugs to conduct board meeting
Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powered b
Read more
04 Nov 24
Beta Drugs schedules EGM
Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 21
Read more
28 Nov 24